Xiao-xing Li

State Key Laboratory Of Oncology In South China
Guangzhou, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications

Erratum: Androgen Receptor Promotes Gastric Carcinogenesis via Upregulating Cell Cycle-Related Kinase Expression: Erratum.

Erratum: Androgen Receptor Promotes Gastric Carcinogenesis via Upregulating Cell Cycle-Related Kinase Expression: Erratum.

Journal: Journal of Cancer
Published: July 14, 2025

Correction: N6-Methyladenosine Reader YTHDF1 Promotes Stemness and Therapeutic Resistance in Hepatocellular Carcinoma by Enhancing NOTCH1 Expression.

Correction: N6-Methyladenosine Reader YTHDF1 Promotes Stemness and Therapeutic Resistance in Hepatocellular Carcinoma by Enhancing NOTCH1 Expression.

Journal: Cancer research
Published: June 20, 2025

Bacteria-metabolite butyrate boosts anti-PD1 efficacy in colorectal cancer patient-derived organoids through activating autologous tumour-infiltrating GNLY +CD8+ T cells.

Bacteria-metabolite butyrate boosts anti-PD1 efficacy in colorectal cancer patient-derived organoids through activating autologous tumour-infiltrating GNLY +CD8+ T cells.

Journal: Gut
Published: March 11, 2025

Erratum: MT1G is Silenced by DNA Methylation and Contributes to the Pathogenesis of Hepatocellular Carcinoma: Erratum.

Erratum: MT1G is Silenced by DNA Methylation and Contributes to the Pathogenesis of Hepatocellular Carcinoma: Erratum.

Journal: Journal of Cancer
Published: December 13, 2024

N6-Methyladenosine Reader YTHDF1 Promotes Stemness and Therapeutic Resistance in Hepatocellular Carcinoma by Enhancing NOTCH1 Expression.

N6-Methyladenosine Reader YTHDF1 Promotes Stemness and Therapeutic Resistance in Hepatocellular Carcinoma by Enhancing NOTCH1 Expression.

Journal: Cancer research
Published: June 27, 2023

Towards precision oncology discovery: four less known genes and their unknown interactions as highest-performed biomarkers for colorectal cancer.

Towards precision oncology discovery: four less known genes and their unknown interactions as highest-performed biomarkers for colorectal cancer.

Journal: NPJ precision oncology
Published: June 02, 2023

Personalized drug screening using patient-derived organoid and its clinical relevance in gastric cancer.

Personalized drug screening using patient-derived organoid and its clinical relevance in gastric cancer.

Journal: Cell reports. Medicine
Published: April 14, 2023

Hepatitis B virus-related intrahepatic cholangiocarcinoma originates from hepatocytes.

Hepatitis B virus-related intrahepatic cholangiocarcinoma originates from hepatocytes.

Journal: Hepatology international
Published: February 14, 2023

Personalized drug screening in patient-derived organoids of biliary tract cancer and its clinical application.

Personalized drug screening in patient-derived organoids of biliary tract cancer and its clinical application.

Journal: Cell reports. Medicine
Published: December 05, 2022

The activation of mTOR signalling modulates DNA methylation by enhancing DNMT1 translation in hepatocellular carcinoma.

The activation of mTOR signalling modulates DNA methylation by enhancing DNMT1 translation in hepatocellular carcinoma.

Journal: Journal of translational medicine
Published: November 04, 2022

SEPT2 crotonylation promotes metastasis and recurrence in hepatocellular carcinoma and is associated with poor survival.

SEPT2 crotonylation promotes metastasis and recurrence in hepatocellular carcinoma and is associated with poor survival.

Journal: Cell & bioscience
Published: October 25, 2022

Mechanistic insight of SARS-CoV-2 infection using human hepatobiliary organoids.

Mechanistic insight of SARS-CoV-2 infection using human hepatobiliary organoids.

Journal: Gut
Published: November 21, 2021
Showing 1-12 of 25

Last Updated: 09/26/2026